Capital Investment Counsel Inc’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-288
| Closed | -$205K | – | 253 |
|
|
2024
Q4 | $205K | Hold |
288
| – | – | 0.03% | 182 |
|
|
2024
Q3 | $303K | Hold |
288
| – | – | 0.04% | 148 |
|
|
2024
Q2 | $303K | Hold |
288
| – | – | 0.05% | 146 |
|
|
2024
Q1 | $277K | Hold |
288
| – | – | 0.05% | 153 |
|
|
2023
Q4 | $253K | Hold |
288
| – | – | 0.04% | 152 |
|
|
2023
Q3 | $237K | Sell |
288
-125
| -30% | -$103K | 0.05% | 148 |
|
|
2023
Q2 | $297K | Buy |
413
+13
| +3% | +$9.34K | 0.06% | 135 |
|
|
2023
Q1 | $329K | Hold |
400
| – | – | 0.08% | 127 |
|
|
2022
Q4 | $289K | Buy |
400
+100
| +33% | +$72.1K | 0.07% | 134 |
|
|
2022
Q3 | $207K | Sell |
300
-100
| -25% | -$69K | 0.06% | 142 |
|
|
2022
Q2 | $236K | Buy |
400
+50
| +14% | +$29.5K | 0.06% | 149 |
|
|
2022
Q1 | $244K | Buy |
350
+25
| +8% | +$17.4K | 0.05% | 156 |
|
|
2021
Q4 | $205K | Buy |
+325
| New | +$205K | 0.04% | 177 |
|
|
2018
Q3 | – | Sell |
-725
| Closed | -$250K | – | 152 |
|
|
2018
Q2 | $250K | Buy |
+725
| New | +$250K | 0.1% | 126 |
|
|
2017
Q4 | – | Sell |
-525
| Closed | -$235K | – | 149 |
|
|
2017
Q3 | $235K | Hold |
525
| – | – | 0.1% | 130 |
|
|
2017
Q2 | $258K | Sell |
525
-50
| -9% | -$24.6K | 0.11% | 123 |
|
|
2017
Q1 | $223K | Hold |
575
| – | – | 0.1% | 135 |
|
|
2016
Q4 | $211K | Sell |
575
-385
| -40% | -$141K | 0.1% | 129 |
|
|
2016
Q3 | $386K | Buy |
+960
| New | +$386K | 0.19% | 95 |
|